News
Evaluating Arcutis Biotherapeutics: Insights From 5 Financial Analysts
12 Apr 24
Analyst Ratings
Needham Reiterates Buy on Arcutis Biotherapeutics, Maintains $16 Price Target
12 Apr 24
News, Price Target, Reiteration, Analyst Ratings
EQT, Genie Energy And Other Big Stocks Moving Lower On Monday
11 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Arcutis Announces Acceptance Of Late Breaking Abstract In Atopic Dermatitis Among Five New Topical Roflumilast Data Being Presented At The American Academy Of Dermatology Annual Meeting
4 Mar 24
Biotech, News, Events, General
Arcutis Prices $150M Public Offering Of 15,789,474 Common Shares At $9.50/Share
29 Feb 24
News
Arcutis And Sato Announce Strategic Collaboration And Licensing Agreement For Topical Roflumilast In Japan; The Arcutis To Receive A $25M Upfront Payment, And Is Eligible To Receive Potential Development And Commercial Milestone Payments Totaling $40M
28 Feb 24
Biotech, News, Contracts, Global, General
Goldman Sachs Maintains Neutral on Arcutis Biotherapeutics, Raises Price Target to $11
28 Feb 24
News, Price Target, Analyst Ratings
Mizuho Reiterates Buy on Arcutis Biotherapeutics, Raises Price Target to $17
28 Feb 24
News, Price Target, Reiteration, Analyst Ratings
Breaking Down Arcutis Biotherapeutics: 4 Analysts Share Their Views
28 Feb 24
Analyst Ratings
Needham Maintains Buy on Arcutis Biotherapeutics, Raises Price Target to $16
28 Feb 24
News, Price Target, Analyst Ratings
Arcutis Biotherapeutics Q4 2023 GAAP EPS $(0.72) Beats $(0.76) Estimate, Sales $13.53M Beat $11.34M Estimate
27 Feb 24
Earnings, Earnings Beats, News
Arcutis Biotherapeutics Q4 GAAP EPS $(0.72) Beats $(0.78) Estimate, Sales $13.53M Beat $11.34M Estimate
27 Feb 24
Earnings, News
Earnings Scheduled For February 27, 2024
27 Feb 24
Earnings
10 Health Care Stocks Whale Activity In Today's Session
19 Feb 24
Options
12 Health Care Stocks Moving In Friday's Intraday Session
9 Feb 24
Movers
MaxLinear Reports Q4 Results, Joins ING, Wolfspeed And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
1 Feb 24
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Press releases
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
5 Apr 24
Press Releases
Arcutis to Present at the 23rd Annual Needham Virtual Healthcare Conference
28 Mar 24
News, Press Releases
Arcutis Presents Late-Breaking Data From INTEGUMENT-PED Phase 3 Trial of Roflumilast Cream 0.05% in Atopic Dermatitis in Children Ages 2 to 5 at the American Academy of Dermatology Annual Meeting
10 Mar 24
Press Releases
New Research Reveals Genomic Profile of Seborrheic Dermatitis and Answers Key Questions on Immune Response and Skin Barrier Dysfunction
9 Mar 24
Analyst Ratings, Press Releases
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
5 Mar 24
Health Care, Press Releases
Arcutis Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
4 Mar 24
Press Releases
Arcutis to Present at the TD Cowen 44th Annual Health Care Conference
29 Feb 24
News, Press Releases
Arcutis Announces Pricing of $150 Million Public Offering
28 Feb 24
Press Releases
Arcutis and Sato Announce Strategic Collaboration and Licensing Agreement for Topical Roflumilast in Japan
28 Feb 24
Press Releases, General
Arcutis Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
27 Feb 24
Earnings, Press Releases
Arcutis to Report Fourth Quarter and Full Year 2023 Financial Results
16 Feb 24
News, Press Releases
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
6 Feb 24
Health Care, Press Releases